<DOC>
	<DOCNO>NCT00723216</DOCNO>
	<brief_summary>The primary objective study evaluate effect enoxaparin venous thromboembolism incidence bleed rate ( major minor bleed ) patient undergo curative abdominal cancer surgery . The secondary objective evaluate incidence adverse event enoxaparin patient .</brief_summary>
	<brief_title>Japanese Efficacy Safety Study Enoxaparin Patients With Curative Abdominal Cancer Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Abdominal Neoplasms</mesh_term>
	<criteria>Malignant tumor patient undergo laparotomy surgery expect take 45 minute . surgery laparoscope endoscopic operation clinical sign deep vein thrombosis use nonsteroidal antiinflammatory drug surgery completion initial administration severe hepatic disease renal disease woman childbearing potential , pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Prevention</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>curative surgery</keyword>
</DOC>